Before founding Sound Bioventures, Casper was a Senior Partner at Lundbeckfonden Ventures, where he worked for 12 years, and led investments and served as Board director in companies including: Sanifit (sold to Vifor Pharma), Aura Biosciences (Nasdaq: AURA), Spero Therapeutics (Nasdaq: SPRO), Nexstim (Nasdaq First North: NXTM) and Biomup (Euronext: BUP).
Prior to that, he was CEO of the venture backed diagnostics company ilochip A/S (technology sold to DELTA, now FORCE Technology). Before that Casper worked in the pharmaceutical industry for 15 years in a range of different positions in R&D, Project Management, Sourcing, Quality Assurance, and Business Development & Strategy, for Lundbeck, Novo Nordisk and Niels Clauson-Kaas. While working at Lundbeck, Casper was part of the team that span Veloxis (sold to Asahi Kasei) out of Lundbeck, and served on the board of the Lundbeck Foundation.
Based in Copenhagen, DK.
